for Sep 16, 2020
National Institute of Allergy and Infectious Diseases Director Dr. Anthony Fauci said he believes a coronavirus vaccine may be proven safe and effective by November or December of this year https://t.co/NEIR2apDNW
— CNN (@CNN) September 16, 2020
Infectious Diseases at that time, he likely knew of HCQ’s effectiveness in fighting coronaviruses as early as 2005.
— Tracy Beanz (@tracybeanz) September 16, 2020
READ MORE: https://t.co/rN09gpoyEe
No role for prophylactic antibiotics or probiotics in the treatment of Acute pancreatitis
— Antibiotic Steward🆔 Bassam Ghanem (@ABsteward) September 16, 2020
A Masterpiece Review Article @MarcBesselink of management of Acute pancreatitis @TheLancet #IDTwitter https://t.co/JZ267ZQLpY pic.twitter.com/vaxRmwgCcM
Most antimicrobial stewardship efforts are focused on hospitals, not primary care.
— Madhu Pai (@paimadhu) September 16, 2020
2 studies show high levels of antibiotic over-prescription for conditions that are common in primary carehttps://t.co/gTM8PJa7ku via @PLOSMedicine https://t.co/fXxSmhxikZ via @GlobalHealthBMJ pic.twitter.com/XQy16LRw8x
Revive Therapeutics Announces IRB Approval of US Expanded Access Treatment Program (Compassionate Use) for Bucillamine in COVID-19 | $RVV #covid19 #coronavirus #infectiousdiseases #clinicalstudy #medicalindustry #psilocybin #bucillamine #pharmaceutical | https://t.co/TnNhEzxMwu
— Revive Therapeutics (@Revive_RVV) September 16, 2020
Viruses are key drivers of evolution and ecosystem function, but viruses infecting early-diverging lineages of fungi have been almost entirely unstudied. In @mBioJournal, researchers report mycovirus diversity and abundance using two approaches. https://t.co/PnDKtclt8S pic.twitter.com/tusaWDkaIr
— ASM (@ASMicrobiology) September 16, 2020
🔥Excellent RCT 🔥@TheLancetInfDis
— Antibiotic Steward🆔 Bassam Ghanem (@ABsteward) September 16, 2020
Disappointing results!
In adults at risk for CDI difficile a bivalent C difficile toxoid vaccine did NOT prevent CDI.
The study was terminated after the first planned interim analysis because of futility. #IDTwitter https://t.co/UVrHzYfMrk
🔥News release 🔥
— Antibiotic Steward🆔 Bassam Ghanem (@ABsteward) September 16, 2020
Lilly announces proof of concept data from an interim analysis of the BLAZE-1 RCT showing a reduced rate of hospitalization for symptomatic #COVID19 patients in the outpatient setting treated with LY-CoV555 " Lucky triple 5 "https://t.co/HzGqYk0l2r pic.twitter.com/07l6PjX0yB
🔥Very interesting🔥 #OFID by Dr. Daniel Musher
— Antibiotic Steward🆔 Bassam Ghanem (@ABsteward) September 16, 2020
Normal Respiratory Flora as a Cause of Community-Acquired Pneumonia
A causative organism could be identified in >95% of patients hospitalized for CAP. #IDTwitter https://t.co/v9JUlc41up pic.twitter.com/3OqHCNoJQo
New research Article: Safety, immunogenicity, and efficacy of a Clostridioides difficile toxoid vaccine candidate: a phase 3 multicentre, observer-blind, randomised, controlled trial https://t.co/c821zqwVtF #Cdiff
— The Lancet Infectious Diseases (@TheLancetInfDis) September 16, 2020
NEW #CID using large NDTI dataset,clinicians defaulted 10d courses for most conditions, regardless of guideline-recommendations. Median antibiotic course
— Antibiotic Steward🆔 Bassam Ghanem (@ABsteward) September 16, 2020
duration was 10 days for all conditions except acute cystitis. #IDTwitter https://t.co/WTJBFEcRtk pic.twitter.com/TAx7twUoTo
⛔Update⛔
— Antibiotic Steward🆔 Bassam Ghanem (@ABsteward) September 16, 2020
In patients with "moderate" #COVID19 admitted to the hospital without the need for supplemental oxygen &oxygen saturation >94% on room air, @IDSAInfo suggests against the routine use of remdesivir
SIMPLE RCT Spinner et Al
Suggest not recommend https://t.co/tqyEBiLQQ7 pic.twitter.com/VONlhTaAcB
I cant understand what the UK Gov are doing. According to the Gov web page, Covid-19 was downgraded to a nasty case of the Flu in March. and was no longer listed as a Serious Infectious Diseasehttps://t.co/bPs5qHMMwH
— Erewhon (@Erewhon_Tramp) September 16, 2020
Top HHS spokesman apologizes to staff for accusing government scientists of sedition - @CNNPolitics apologizing is not enough. He needs to be fired and @CDCDirector should demand nothing less from @SecAzar https://t.co/qSvEimVo33
— Carlos del Rio (@CarlosdelRio7) September 16, 2020
In @Forbes, Dr. @RodneyRohde highlights the need for improved public health/research funding on AMR during the pandemic and speaks with Dr. @IDstewardship about how antimicrobial stewardship plays a fundamental role across COVID-19 response (6/6) https://t.co/ORwSNdTfSF
— CIDRAP-ASP (@CIDRAP_ASP) September 16, 2020
If you're interested in making yourself a better clinician/scientist/person/tweeter, take a few minutes and study Figure 3 and the associated discussion
— Eric Wenzler (@TheIDApprentice) September 16, 2020
Right @julie_justo ?https://t.co/Khxo5RH8rD
Using Prior Culture Results to Improve Initial Empiric Antibiotic Prescribing: An Evaluation of a Simple Clinical Heuristic. #IDTwitter #CID https://t.co/WaS5WJlnuz
— Antibiotic Steward🆔 Bassam Ghanem (@ABsteward) September 16, 2020
March 2019 (Ready to release) Research at the Wuhan Institute of Virology. Funding by China’s National Science and Technology Major Project on Infectious Diseases. Viruses do not just walk out of a BSL Level 4 National laboratory. Published in PUBMED https://t.co/2Wd768hxke
— Becky in Texas (@Trump2020Texas) September 16, 2020
On This Week in Microbiology: How enzyme delivery into competitor cells leads to synthesis of (p)ppApp, depletion of ATP, dereg. of metabolic pathways, & cell death, & a refinement of our typical view of bacterial lag phase as a period of nonreplication https://t.co/tRDkeTS6YS
— ASM (@ASMicrobiology) September 16, 2020
Association of Daily Wear of Eyeglasses With Susceptibility to COVID-19 Infection.
— Antibiotic Steward🆔 Bassam Ghanem (@ABsteward) September 16, 2020
A provocative study raises the possibility that use of eye protection by the general public might offer some degree of protection from #COVID19
https://t.co/MeQGJySjEy @JAMAOphth @JAMANetwork
There's still time to join our latest run of "Antimicrobial Stewardship for Africa" - our 3 week online learning course. Learn all about antimicrobial resistance in Africa and how best to tackle it alongside a global learning community!#BSACAfrica #AMShttps://t.co/QMfxz08tFz pic.twitter.com/5vhgwCHO8n
— BSAC (@BSACandJAC) September 16, 2020
Would have loved to see presence/lack of an ASP and/or RDTs as a covariate in this. Regardless, more evidence that TTET is driver of mortality, not resistance@lodise_tom https://t.co/WNWby1dt5r
— Eric Wenzler (@TheIDApprentice) September 16, 2020
🔥Just published today. Another study that questions the role of empiric aminoglycosides in the management of neutropenic fever - this time in children. Time to revisit the guidelines? @NCICancer @PeterMacRes @brendanmcID #PICNICC https://t.co/FCP3DmXR5N
— NCAS_Australia (@NCAS_Aus) September 16, 2020
.@CDCDirector is right, masks work and we will not have a #COVID19 vaccine widely available until mid to late 2021 @NYTimes https://t.co/3a4cunUCNz
— Carlos del Rio (@CarlosdelRio7) September 16, 2020
"Early evidence and anecdotal accounts suggest that, since the pandemic started, there have been changes in hospital practices and an increase in antibiotic use"@glbuckland explains how COVID-19 could be accelerating drug resistance 💊💊💊https://t.co/DBKyb09YOU
— AMR at Wellcome (@Wellcome_AMR) September 16, 2020
My bread-and-butter framework comes from @SusanMichie and colleagues: The behaviour change wheel: a new method for characterising and designing behaviour change interventions. doi: 10.1186/1748-5908-6-42https://t.co/aqGjBINXk2 pic.twitter.com/bjwksZJkJl
— Andrew Morris (@ASPphysician) September 16, 2020
🔥Very interesting🔥
— Antibiotic Steward🆔 Bassam Ghanem (@ABsteward) September 16, 2020
Initiating first cART regimens with INSTIs or PIs vs. NNRTIs may confer greater risk of DM, likely mediated through weight gain.This effect was most pronounced for raltegravir vs. NNRTI-initiators #IDTwitter #CID https://t.co/yt3jPRF6Qh
Read the special issue of #JID highlighting the need for diversity in building the future ID workforce #IDAEinJID https://t.co/NYbsWoFFtU via @IDSAInfo
— Carlos del Rio (@CarlosdelRio7) September 16, 2020
Cannot emphasize this enough. With lineups growing, going to get tested with no sx/exposure means those with sx have longer waits in line, turnaround times, and absenteeism. Kids are out of school longer. Avoid the assessment centers with no symptoms https://t.co/EHKCakkofa
— Zain Chagla (@zchagla) September 16, 2020
.@UGAEcology researchers have used machine learning to predict the reemergence of existing infectious diseases. The algorithm monitors public health data to detect statistical patterns associated with impending outbreaks. https://t.co/YfIJZfTsw0
— UGA (@universityofga) September 16, 2020
Don’t miss @TheLancet journals’ session details & related content for #ECCVID @ESCMID! Sign up for Lancet Conference Alerts | Infectious Diseases today: https://t.co/eb4Htp8Lbc pic.twitter.com/Qw5rDNEJgZ
— The Lancet (@TheLancet) September 16, 2020
Interested in the latest #COVID19 research? Join us on Sept. 17 for a live discussion of a study that demonstrates the inhibitory effects of remdesivir in human lung cells in vitro by targeting the RNA-dependent RNA polymerase of SARS-CoV-2. Learn more: https://t.co/Y3qUXIUEQg pic.twitter.com/DgBdDcXxgj
— ASM (@ASMicrobiology) September 16, 2020
Today, FDA, @CDCgov, other public health departments discuss lessons learned from a decade of leafy green outbreaks in the Emerging Infectious Diseases journal. https://t.co/KMSIiWw6ZV
— U.S. FDA (@US_FDA) September 16, 2020
Watch the recording of today's NCAS JC webinar w/ @TeresaWozniak_ @MenziesResearch on 'Antimicrobial resistance blind spots: strengthening disease surveillance and response in regional Australia' here! - https://t.co/cAx3VSInEZ
— NCAS_Australia (@NCAS_Aus) September 16, 2020
Worth reading @AmberSchmidtke take on the GA #COVID19 pandemic as she unpacks the most recent WH #Coronavirus Task Force report. You can read it here: https://t.co/lsdmEYrJ5B
— Carlos del Rio (@CarlosdelRio7) September 16, 2020
Here's some good news: "This may be the first time such bacteria have been found in wild mammal nests. That makes the 1-meter-high nests a potential new source of antibiotics. 'It’s a pretty incredibly unique environment.'” https://t.co/KeCYyxVv1I #AntibioticResistance
— Battle Superbugs (@battlesuperbugs) September 16, 2020
Welcome updates from @IDSAInfo on the use of #remdesivir for hospitalized patients with #COVID-19: do NOT recommend use in patients with a room air O2 saturation > 94%https://t.co/6FbRVHQ6ta pic.twitter.com/CCSxg9r4cr
— Mike Stevens (@Dr_Mike_Stevens) September 16, 2020
Does it matter that the Covid-19 virus is mutating? | @Health24com https://t.co/EwXUwHPyw5 pic.twitter.com/DOGzPOb2VM
— News24 (@News24) September 16, 2020
Revive Therapeutics Announces IRB Approval of US Expanded Access Treatment Program (Compassionate Use) for Bucillamine in COVID-19 | $RVV $RVVTF #covid19 #coronavirus #infectiousdiseases #clinicalstudy #psilocybin #bucillamine #revivetherapeutics https://t.co/o9gC6KjGMo https://t.co/jVgFKJYzmS
— Andrew MacDonald (@andrewmacdo) September 16, 2020
Want to learn about applying #AntimicrobialStewardship strategies in your practice?
— TARGETantibiotics (@TARGETabx) September 16, 2020
Check out the #Prescribing in #PrimaryCare course by @TARGETabx @BSACandJAC!
📝Complete at your own pace
🗨️Comment and engage
✅Learn via engaging videos
Join now👉https://t.co/RM6RS23qJj pic.twitter.com/aINt45xii7
Our new #JInfectDis supplement highlights the importance of nurturing a diverse next generation of clinicians, scientists & leaders in ID to reflect the diversity of our patients: https://t.co/UUNwjg7yuG
— IDSA (@IDSAInfo) September 16, 2020
Our news release: https://t.co/kVKkxVtub7#IDAEinJID #FutureofID pic.twitter.com/RjPe5kI7G9
Why is this the year to make sure you get your flu shot? Longtime infectious diseases expert Dr. Robert Webster explains. https://t.co/F8soZTn2Y8 @NatGeo #Twindemic pic.twitter.com/BWQwu38joD
— St. Jude Research (@StJudeResearch) September 16, 2020
Congratulations to all involved in the recently published 2020 IDA&E JID supplement and to Dr. Bill Powderly past @IDSAInfo president for his contribution & leadership on the Importance of IDA&E to the Future of the Infectious Diseases Society of Americahttps://t.co/tU8zhmzuXd
— Washington University ID Division (@WashUID) September 16, 2020
Peering Through the Glass Ceiling: A Mixed Methods Study of Faculty Perceptions of Gender Barriers to Academic Advancement in Infectious Diseases https://t.co/t38XEBXejj. We talk about “mentoring” but “sponsorship” as as important or even more important in closing the gender gap.
— Carlos del Rio (@CarlosdelRio7) September 16, 2020
NEW from @CDCgov: evidence-based recommendations for prevention and control of Staphylococcus aureus in neonatal intensive care units (NICUs). Protecting vulnerable infants from infections is a priority, and these recommendations can help. Learn more: https://t.co/ON2AEpmNOK
— Battle Superbugs (@battlesuperbugs) September 16, 2020
‘Nudge’ letters prompt sustained drop in #antibiotic prescribing https://t.co/IuMxlH2S7v
— Brad Langford (@BRxAD) September 16, 2020
“Every extra day of unnecessary #antibiotics increases the risks of C. diff and #antibioticresistance,” @OSUWexMed’s Dr. Debra Goff warns. https://t.co/5JeEGWa2SY
— Save Antibiotics (@saveantibiotics) September 16, 2020
It just came out in Trends in Parasitology: 'α-Gal-Based Vaccines: Advances, Opportunities, and Perspectives'... One Vaccine fitting the One Health strategy for the control of infectious diseases...https://t.co/On4tHFbPRz pic.twitter.com/pFJGZzLTZ1
— Alejandro Cabezas-Cruz (@ACabezasCruz) September 16, 2020
IL-26 mediated human cell activation and antimicrobial activity against #Borrelia burgdorferihttps://t.co/cx2aq6R2oB #LymeDisease #Lyme pic.twitter.com/wrPCwmoLEk
— Microbes&Infection (@MicrobesInfect) September 16, 2020
Fears of a 'perfect storm' as flu season nearshttps://t.co/jY8KtsM4Gq #COVID19 #influenza #fluvax pic.twitter.com/sqMb7eatFL
— CIDRAP (@CIDRAP) September 16, 2020
In WP1's new study, 2 European regions will join forces to obtain information on the disease burden of two of the least studied infectious diseases in this age group in Europe. Read more: https://t.co/dAvGo0c6jt@GVAfisabio @SSI_dk #vaccines #elderlylivesmatter #publichealth
— VITAL (@VITAL_Europe) September 16, 2020
Top story: Management of drug toxicity in M. avium complex pulmonary disease – an expert panel survey | Clinical Infectious Diseases | Oxford Academic https://t.co/5Ftzx6bAVH, see more https://t.co/jgCeENQuZt
— Juan C Ivancevich MD (@Aller_MD) September 16, 2020
The biofilm matrix protein CdrA plays a common role as a biofilm matrix cross-linker across P. aeruginosa isolates with different exopolysaccharides. @JBacteriology https://t.co/mr0PcHs3yC pic.twitter.com/JVERr0B8qC
— ASM (@ASMicrobiology) September 16, 2020
Today whilst walking in the woods we witnessed about six People wearing face masks ...You could see the fear in their eyes ..All for a virus ,which the uk government downgraded back in March and have never changed that status since then. https://t.co/WZpR3Mj2oa
— Jab (@Jab03919711) September 16, 2020
Despite US President Donald Trump's claims of a COVID-19 vaccine within a month, experts including top US government infectious diseases doctor Anthony Fauci say vaccine approval is more likely toward the end of the year. https://t.co/1gcVuys5ZA pic.twitter.com/yQlaaOOFK3
— Inquirer (@inquirerdotnet) September 16, 2020
The situation update on #coronavirus has been updated on our website (16 September at 16:10).
— THL (@THLorg) September 16, 2020
🔹Samples tested: approx. 837,100
🔹Reported cases: 8,750
🔹Recovered: approx. 7,700
🔹Hospitalised: 14
🔹In intensive care: 3
🔹Deaths: 339
Read more 👇 https://t.co/sdGQYvL8Wx
"COVID-19: A scholarly production dataset report for research analysis" - new article from Data in Brief https://t.co/hZYL7FaEYz #researchdata #infectiousdiseases pic.twitter.com/t32xdMC3tX
— Elsevier Research Data (@DataElsevier) September 16, 2020
A cluster is used more frequently in Non communicable https://t.co/ZE04SZrCUg a cluster of cancer cases. Tends to be cases occurring geographically close to each other. Outbreak used for infectious diseases
— Patricia Fitzpatrick (@patriciaefitz) September 16, 2020
C. neoformans isolates that produce melanin faster are more frequent targets of nonlytic exocytosis and escape the macrophage. Melanin is produced by laccase, which appears to be an important regulator of nonlytic exocytosis of C. neoformans. @mBioJournal https://t.co/92leCMVlgu pic.twitter.com/aj1zsTCJHi
— ASM (@ASMicrobiology) September 16, 2020
New in CID: A call for a renewed commitment to rid science of racism & bias & to promote diversity so physician-scientists can more effective at innovating & delivering therapeutics to patients: https://t.co/W8vklT3EsR@taliaswartz @Boghuma #IDSAJournals #FutureofID
— IDSA (@IDSAInfo) September 16, 2020
Here's microbiome study we did in lung tx a few yrs ago. "...even bacteria normally considered to be strictly commensal, such as Corynebacterium, may cause pneumonia as the surrounding microbiome is depleted and corresponding host responses are altered." https://t.co/lW5f4a4Qvq
— Neil Clancy (@ClancyNeil) September 16, 2020
After an asteroid wiped out the dinosaurs, ocean microbes helped life rebound.
— Microbes&Infection (@MicrobesInfect) September 16, 2020
The asteroid impact that killed most of the dinosaurs 66 million years ago also created conditions for ocean microbes to flourish, according to a new study.https://t.co/q2xI3Etzsc #microbiology
NOW LIVE❗ Free course on #antimicrobial stewardship.
— EWMA (@EWMAwound) September 16, 2020
Learn more and sign up➡️ https://t.co/4uJ1cV4yWq
Join the discussion with experts from EWMA and the British Society of Antimicrobial Chemotherapy on #AMS in #woundcare. https://t.co/ouOcGkKMKx
We produce the infectious disease weekly report for Ireland - the latest report is available on the HPSC website now https://t.co/mlk44sB3fr #thisispublichealth #vaccineswork #infectiousdiseases pic.twitter.com/iZrp0dqS8i
— HSE Health Protection Surveillance Centre (HPSC) (@hpscireland) September 16, 2020
The IDEAL project represents the first attempt to study the complete pathogen landscape of any species and a unique resource for the research community interested in infectious diseases of cattle in East Africa. Learn more: https://t.co/20606yhYQa #BigDatainAg #OneHealth @ILRI pic.twitter.com/NvTqQM2gG3
— CGIAR (@CGIAR) September 16, 2020
📣ICYMI: Dr. Karim Ali, Director, Division of Infectious DIseases, talked to @610CKTB about:
— NiagaraHealth (@niagarahealth) September 16, 2020
➡️Increase in Ontario's COVID cases and importance of infection prevention and control measures
➡️Virus mutations and what we know so far
Listen to the interview: https://t.co/k157XtWp1w pic.twitter.com/e6zVWDmpXv
Dr. Harriet Robinson will present progress on GeoVax's HIV preventive vaccine and the COVID-19 vaccine program at the Vaccine Congress Washington https://t.co/e2ywjetyID #vaccines #HIV #prevention #COVID-19 #infectiousdiseases $GOVX pic.twitter.com/FK1dD8HZU8
— GeoVax, Inc. (@Geovax_News) September 16, 2020
Southern Hemisphere Has Fewer Flu Cases Amid COVID https://t.co/Grj1AfNnDS from @WebMD. #WearAMask #watchYourDistance #washyourhands & get a flu shot and you will avoid getting #COVID19 & Influenza.
— Carlos del Rio (@CarlosdelRio7) September 16, 2020
#ImportantUpdates to the Mx of coexisting conditions in the context #COVID19 topic includes a study on the impact of social distancing on other infectious diseases in children. The incidence of croup, bronchiolitis & influenza significantly decreased https://t.co/zW4sXzscZv pic.twitter.com/LpXR9dDBvx
— BMJ Best Practice (@BMJBestPractice) September 16, 2020
Human Immunodeficiency Virus Type 1 RNA Detected in the Central Nervous System (CNS) After Years of Suppressive Antiretroviral Therapy Can Originate from a Replicating CNS Reservoir or Clonally Expanded Cells. https://t.co/quCQRLcpgs
— AntibioticResistance (@AntibioticResis) September 16, 2020
Researchers develop a Gut Microbiome Health Index (a biologically-interpretable mathematical formula) that can use a gut #microbiome profile from a person's stool sample to reveal the likelihood of having a disease independent of the clinical diagnosis.https://t.co/G2prCPFyI6
— Microbes&Infection (@MicrobesInfect) September 16, 2020
"Comparing GP antibiotic prescribing rates to peer averages led to a 12% drop in prescribing." https://t.co/xCaZJixUo2
— BSAC (@BSACandJAC) September 16, 2020
Association of Daily Wear of Eyeglasses With Susceptibility to Coronavirus Disease 2019 Infection | Infectious Diseases | JAMA Ophthalmology | JAMA Network https://t.co/aDbIIX14y1
— SciArt3D (@SciArt3D) September 16, 2020
BMC shortlists 2 plots for 5000 beds hospital for infectious diseases@diptivsingh @mybmc https://t.co/MkC0xyOL1r
— Free Press Journal (@fpjindia) September 16, 2020
The Wrong Year To Skip Your #Flu Shot with #NFID Medical Director William Schaffner, MD via @IAmBiotech https://t.co/y4K33igsfc #GetVaccinated to help #FightFlu pic.twitter.com/oL5IO4EdLG
— NFID (@NFIDvaccines) September 16, 2020
This was written in November 2019, before #covid19 had exploded worldwide. #ScienceKnows, we should listen to it more.#coronavirus #COVID19 #sustainability #extinction #nature #wildlife #WednesdayThoughts #ClimateChange #ClimateEmergency #ClimateActionhttps://t.co/ca4Re6S4ht
— Brendan May (@bmay) September 16, 2020
Anti-SARS-CoV-2 antibody treatment associated with fewer ED visits or hospitalizations in mildly ill subjects (1.7% of 302 study subjects vs 6% of 150 placebo), only 1 of 3 doses met primary endpoint, per Eli Lilly interim data press releasehttps://t.co/D0Kh8EqVvD
— Tim Lahey (@TimLaheyMD) September 16, 2020
Renminder: We are excited to announce the availability of funding for an ID pharmacotherapy residency for July 2021 - June 2022! For more information and application details, please visit https://t.co/6fHjd0K4Il pic.twitter.com/lYGnR6B1dy
— SIDP (@SIDPharm) September 16, 2020
Cassida rubiginosa passes bacterial symbionts onto its offspring by harboring some of the bacteria in its reproductive tract so it can deposited on eggs.
— Microbes&Infection (@MicrobesInfect) September 16, 2020
A new review examines diverse relationships between holometabolous insects & their gut bacteria.https://t.co/Six5Wwkb7z
In this interview, Dr Duerden talks about the role of fit-for-purpose sore throat guidelines in antimicrobial stewardship, the importance of appropriate symptom relief, and how #coronavirus disease (COVID-19) could represent an opportunity for change. https://t.co/EDjRhMM8yP pic.twitter.com/ByI6XQ0fHL
— EMJ Respiratory (@EMJRespiratory) September 16, 2020
Monoclonal antibodies (mAbs) are a group of powerful medical technologies that are largely inaccessible in Africa despite their promise in treating noncommunicable and infectious diseases. Read article by @ybmoyo1 from @IAVI https://t.co/TJSuedTYKH #ActforAccess
— Ethel Makila (@EthelMakila) September 16, 2020
"Researchers led by Dr. Vincent Munster of NIH’s National Institute of Allergy and Infectious Diseases (NIAID) ... investigated how long the virus remained infectious on these surfaces. @NIH
— Shelby County Health (@ShelbyTNHealth) September 16, 2020
https://t.co/tWkoDubmb6 pic.twitter.com/3wDpZ7IIIv
#Tuberculosis Elimination in the Era of COVID-19: A Moving Target | Clinical Infectious Diseases | Oxford Academic https://t.co/2RLHa9LLfQ
— Eh!woza (@eh_woza) September 16, 2020
If you publish facts they are not conspiracy theories ..So the uk downgraded the virus back in March and have never changed that status ..Fact not a theory. Here is the proof.https://t.co/WZpR3Mj2oa
— Jab (@Jab03919711) September 16, 2020
Chronic wasting disease (CWD) affects cervids but their transmission is unknown. Though CWD-infected animals have prions in their blood, CWD doesn’t appear to be transmitted through the Rocky Mountain Wood tick. @mSphereJ https://t.co/e7GqBVTUJS pic.twitter.com/OPHKFYg9w9
— ASM (@ASMicrobiology) September 16, 2020
Dolutegravir Monotherapy Versus Dolutegravir/Abacavir/Lamivudine for Virologically Suppressed People Living With Chronic Human Immunodeficiency Virus Infection: The Randomized Noninferiority MONotherapy of TiviCAY Trial. https://t.co/uTFXnIrewj
— AntibioticResistance (@AntibioticResis) September 16, 2020
Plus linked Comment: Defending against a difficult clostridioides with a vaccine https://t.co/xf1TIhHUtF #Cdiff
— The Lancet Infectious Diseases (@TheLancetInfDis) September 16, 2020
Total global number of #coronavirus cases approaches 30 million.
— Microbes&Infection (@MicrobesInfect) September 16, 2020
India surpassed the 5 million infections milestone, becoming the 2nd nation to hit the grim marker as it continues to report >90,000 cases a day.
Only the US has had more cases.https://t.co/UKf0CLFo9B #COVID19
“He expressed thanks to Anthony S. Fauci, director of the National Institute of Allergy and Infectious Diseases and a member of the White House coronavirus task force, for conferring with his personal physician”- that’s what doctors do. We help people. https://t.co/YQtC0f78IV
— Shmuel Shoham (@ShohamTxID) September 16, 2020
STEWARDSHIP / RESISTANCE SCAN: C diff vaccine candidate fails phase 3; Prior patient cultures for better antibiotics Rxhttps://t.co/deeIRQXrah #AMR #AntibioticStewardship #Cdiff
— CIDRAP (@CIDRAP) September 16, 2020
Can people get COVID-19 more than once? Questions about reinfection and long-term immunity to #SARSCoV2 have circulated for months. In this Microbial Minutes, we evaluate recently published data that's beginning to shed light on this subject. Tune in here: https://t.co/ace3P2tAgJ
— ASM (@ASMicrobiology) September 16, 2020
A new method for the detection of SARS-CoV-2 combines simplified extraction of RNA with isothermal amplification and CRISPR (clustered regularly interspaced short palindromic repeats)–mediated detection. @NEJM #COVID19 https://t.co/GUJzeAwpGn pic.twitter.com/M6cjyUCW6K
— Antibiotic Steward🆔 Bassam Ghanem (@ABsteward) September 16, 2020
An infusion of a monoclonal #antibody was associated with lower hospitalisation rates for #COVID19 , lower viral loads and fewer symptoms; HOWEVER, the data haven’t been published or peer-reviewed. Also, an infusion will probably be expensive. https://t.co/f4Q85VSHlW
— Sanjaya Senanayake (@sanj971) September 16, 2020
Davey Smith, our chief of infectious diseases talks COVID vaccines, treatments and eating scorpions. @UCSDMedSchool @UCSD_HIV https://t.co/gLW5w0KHLL
— UC San Diego Research (@ResearchUCSD) September 16, 2020
People with Spontaneous Control of HIV Have a Distinctive Reservoir. Excellent summary & comment by @RMKGandhi suggesting some HIV elite controllers have viral reservoir that is “locked down” in a way that keeps the virus from breaking through. https://t.co/wMUIgmVRBg
— Carlos del Rio (@CarlosdelRio7) September 16, 2020
We're proud to be a partner on this important @IMI_JU looking at #Vaccines and Infectious Diseases in ageing populations. @VITAL_Europehttps://t.co/qu70k6Vh0T pic.twitter.com/G1iz0XVViv
— Pfizer EU Policy (@PfizerEUPolicy) September 16, 2020
Infection Risk of COVID-19 in Dentistry Remains Unknown: A... : Infectious Diseases in Clinical Practice https://t.co/qiiYBeH3hI
— OSAP.org (@OSAPtweets) September 16, 2020
Today brings the 1st whisper of success for a class of closely watched drugs that it’s hoped will begin to beat back #COVID19 before vaccines are licensed: monoclonal antibodies. Lucky triple 5
— Antibiotic Steward🆔 Bassam Ghanem (@ABsteward) September 16, 2020
🔥BALZE🔥 https://t.co/LWBDRRy8JF https://t.co/53tjxnEP6C
Use of PrEP in the US. Is Increasing but Still Insufficient. Read my summary and comment in @JWatch ID about this paper in @AnnalsofIM with an excellent editorial by @RWalensky & Kevin Ard. We spent in 2018 $2B to give PrEP to 204k https://t.co/gaosP78jlZ
— Carlos del Rio (@CarlosdelRio7) September 16, 2020
Minimum Inhibitory Concentrations of Fluoroquinolones and Pyrazinamide Susceptibility Correlate to Clinical Improvement in Multidrug-resistant Tuberculosis Patients: A Nationwide Swedish Cohort Study Over 2 Decades. https://t.co/4xurZy1vPs
— AntibioticResistance (@AntibioticResis) September 16, 2020
Preparing for the Worst, Health Agencies Mount Unprecedented #Flu Shot Drives https://t.co/QbIty97DYC via @pewtrusts #GetVaccinated to help #FightFlu pic.twitter.com/xyRwoOTFpH
— NFID (@NFIDvaccines) September 16, 2020
Here's what we added to our COVID-19 and Antimicrobial Stewardship page today, Sep 16 (1/6) https://t.co/jcvq4EIsEk
— CIDRAP-ASP (@CIDRAP_ASP) September 16, 2020
Is Blood Type Linked to COVID-19 Risk? So at least for now, blood type should not be used to identify which people who become sick with #COVID19 are likely to develop severe disease. @RitaRubin https://t.co/qnLwLiFbRB via @JAMA_current part of @JAMANetwork
— Antibiotic Steward🆔 Bassam Ghanem (@ABsteward) September 16, 2020
@AlysaMartinRX is our PGY-2 ID resident🦠🧪
— URMC Pharmacy Residency (@URMCPharmRes) September 16, 2020
Alysa has interests in antimicrobial stewardship, drug resistance, transplant ID, pediatric ID, and academia. Her ideal job post residency is to be an ID pharmacist 🤓 pic.twitter.com/PAw7hbWmPu
Vaccine shedding. This is the only study I ever found. I got shingles from someone that was vaccinated. https://t.co/kqV57bXeer
— Wellness Uncoded ❌ (@WellnessUncoded) September 16, 2020
Researchers use whole #genome #sequencing to identify mechanisms of #Paeruginosa resistance to ceftolozane-tazobactam
— DDNews Online (@DDNewsOnline) September 16, 2020
Identify mutations in #ceftolozane targets as well as in DNA replication machineryhttps://t.co/bL6jp4lNHT#microbiology #InfectiousDiseases #WGC pic.twitter.com/iNUepUTreB
Article from the CDC's Journal of Infectious Diseases in May 2020 - https://t.co/BzLsVa0mhB . It reviews 10 RCT's looking at community use of masks to reduce spread of influenza. Conclusion: "No significant reduction in influenza transmission with the use of face masks."
— Dave Tagge (@dave_tagge) September 16, 2020
Contribute your research to @planperjournal exploring how past challenges of infectious diseases has been constructed through the context of planning. Learn more here: https://t.co/SE1SuGrjFZ @julietpdavis pic.twitter.com/1C0oTMKsXK
— Routledge Geog&Built (@RoutledgeGPU) September 16, 2020
In ~1m blood donations in US only 2% had ABs to SARS2. Although donors are not rep of US popn, and localized levels will be much much higher, suggests a long road ahead
— Dr Éilis O’Reilly (@EpiEor) September 16, 2020
| Infectious Diseases | JAMA https://t.co/AqsyF0K3eJ
NAPLEX Question of the Week: Overdose Management https://t.co/76fTXZiSxX #accessmedicine
— Chris Bland (@blandman19) September 16, 2020
Created by Cameron Forbes. Last updated September 19, 2020 at 05:08 EST.